Sequencing on Compact Disc?; Microgenomics of Breast Cancer; Better Binding Site Prediction

PATENT WATCH | Sequencing on Compact Disc? Burstein Technologies of Irvine, Calif., has entered the alternative sequencing strategy arena (see related article, Beyond Sanger: Toward the $1,000 Genome), winning patent protection for its hybridization-based sequencing approach, which employs the company's BioCompact Disc (BCDT) technology. (US patent 6,566,069, issued May 30, 2003) "Oligonucleotide arrays hold great promise in gene sequencing," inventor Jorma Virtanen writes in the applicati

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

PATENT WATCH | Sequencing on Compact Disc?

Burstein Technologies of Irvine, Calif., has entered the alternative sequencing strategy arena (see related article, Beyond Sanger: Toward the $1,000 Genome), winning patent protection for its hybridization-based sequencing approach, which employs the company's BioCompact Disc (BCDT) technology. (US patent 6,566,069, issued May 30, 2003)

"Oligonucleotide arrays hold great promise in gene sequencing," inventor Jorma Virtanen writes in the application. But applying these to de novo sequencing projects is problematic, in that the number and length of required oligos becomes prohibitive. Burstein's approach offers a technical workaround. One embodiment first determines all 16-mer sequences in the sample, followed by all 8-mer sequences that flank unknown 11-mers. The former dataset fleshes out the latter, allowing "almost unequivocal deduction of the original sequence," Virtanen writes. "Only some long repeat sequences are outside the capability of this method," and these can usually be deduced using custom-made arrays.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Ivan Oransky

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours